Global News Roundup: Q3 2022
Windrose Consulting Group, Global News Roundup: Q3 2022
Life science News from around the world
We are pleased to launch the next edition of our quarterly Windrose Consulting Group: Global News Roundup for Q3 2022
In this edition, we look at many key changes in the Global Life Sciences industry, such as: the new Medicare Legislation Passing in the US Senate; a new cross-border HTA alliance between Australia, Canada and the UK; Highly-rated ASMR drugs in France to be subject to updated economic evaluations to limit health expenditure impact; South Africa’s new National Health Insurance scheme is set to be introduced in several stages; plus more coverage from around the world.
Windrose Consulting Group, Strategic guidance for Life Sciences.
Windrose Consulting Group is a privately-held global strategy firm that partners with life science companies to maximize the commercial value of their products, to help meet today’s most critical healthcare needs. We work across a broad range of products and disease areas. Our services that include product commercialization, pricing and market access and value communication. At Windrose, we’re committed to helping companies succeed in bringing innovations to market that enhance people’s lives. We work globally and have three offices, based in Philadelphia (US), London (UK) and Lucerne (Switzerland).